Personalized nutrition is emerging as a major trend in gastroenterology, using microbiome data, biomarkers, genetics, and AI to tailor dietary recommendations to individual patients rather than relying on one-size-fits-all guidance.
The article argues that advances in microbiome science and digital health are enabling more precise management of conditions such as IBS, IBD, and metabolic disorders. As platforms like ZOE and Viome scale personalized testing and recommendations, nutrition is increasingly being positioned as a data-driven clinical intervention that could improve outcomes, reduce trial-and-error treatment, and support more proactive GI care.